Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Woodruff

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Research Square|May 20, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
Nature Communications|August 27, 2021
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDSAartik Sarma, Stephanie A Christenson, Ashley Byrne, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
American Journal of Respiratory and Critical Care Medicine|August 26, 2015
Future Research Directions in Asthma. An NHLBI Working Group ReportBruce D Levy, Patricia J Noel, Michelle M Freemer, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Research Square|May 20, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
Nature Communications|August 27, 2021
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDSAartik Sarma, Stephanie A Christenson, Ashley Byrne, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
American Journal of Respiratory and Critical Care Medicine|August 26, 2015
Future Research Directions in Asthma. An NHLBI Working Group ReportBruce D Levy, Patricia J Noel, Michelle M Freemer, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 34